Session » 4M042 ACR Abstract: Plenary Session II (1816–1821)

Date: Monday, October 22, 2018

Time: 11:00AM-12:30PM

Meeting: 2018 ACR/ARHP Annual Meeting

11:00AM-12:30PM: Abstract Number: 1821

Filgotinib, an Oral, Selective Janus Kinase 1 Inhibitor, Is Effective in Psoriatic Arthritis Patients with an Inadequate Response to Conventional Disease-Modifying Anti-Rheumatic Drugs: Results from a Randomized, Placebo-Controlled, Phase 2 Study

11:00AM-12:30PM: Abstract Number: 1816

Five-Year Outcome of Operative and Nonoperative Management of Meniscal Tear in the Presence of Osteoarthritic Changes

11:00AM-12:30PM: Abstract Number: 1818

Greater BMD Gains with Denosumab Vs Risedronate in Glucocorticoid-Treated Subjects: Results from the Final 24-Month Analysis of a Randomized, Double-Blind, Double-Dummy Study

11:00AM-12:30PM: Abstract Number: 1817

MicroRNA-128 Impairs Cartilage Integrity and Deteriorates Osteoarthritis Pathogenesis through Deregulating Chondrocyte Autophagy

11:00AM-12:30PM: Abstract Number: 1819

MUC5B promoter Variant rs35705950 Is a Risk Factor for Rheumatoid Arthritis – Interstitial Lung Disease

11:00AM-12:30PM: Abstract Number: 1820

Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Severe Scleroderma: Long-Term Outcomes 6-11 Years after Entry on a Randomized Study Comparing Transplantation and Cyclophosphamide

« View all sessions from this meeting